Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

h-index56
i10-index126
Publications450
Citations13,627

Grants

7 total · 7 active

NIH #5R01CA262425-05

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$607K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262425-04

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$609K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262425-03

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$658K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

7 total · 7 active

NIH #5R01CA262425-05

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$607K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262425-04

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$609K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262425-03

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$658K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA262425-02

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$661K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1R01CA262425-01

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

Expiring Soon
Amount
$625K
Period
2021-09-16 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5R01CA287734-02

Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy

Active
Amount
$670K
Period
2024-08-01 → 2029-07-31
PIs
2
Est. capacity / PI
~3 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1R01CA287734-01A1

Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy

Active
Amount
$670K
Period
2024-08-01 → 2029-07-31
PIs
2
Est. capacity / PI
~3 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 100
Open author page on OpenAlex →